Evidence map›Paper›PMID 32630753›Full record

ArticleInternational journal of molecular sciences2020

Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies.

Maximilian Fuchs, Fabian Philipp Kreutzer, Lorenz A Kapsner, Saskia Mitzka, Annette Just, Filippo Perbellini, Cesare M Terracciano, Ke Xiao, Robert Geffers, Christian Bogdan and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect.Journal of cardiovascular development and disease · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Roles of Immune Cells in the Pathogenesis of Fibrosis.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Maximilian FuchsChair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, 91058 Erlangen, Germany.
Fabian Philipp KreutzerInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-7814-9994
Lorenz A KapsnerMedical Center for Information and Communication Technology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.ORCID 0000-0003-1866-860X
Saskia MitzkaInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.
Annette JustInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.
Filippo PerbelliniInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0003-1540-2777
Cesare M TerraccianoNational Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.
Ke XiaoInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.
Robert GeffersHelmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Christian BogdanMikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany.
Hans-Ulrich ProkoschChair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, 91058 Erlangen, Germany.
Jan FiedlerInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0003-4360-1511
Meik KunzChair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, 91058 Erlangen, Germany.
Medizinische Hochschule Hannover · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Erlangen · DEHelmholtz Centre for Infection Research · DEImperial College London · GB

Funding

BHF Centre for Regenerative Medicine at Imperial College London RM/17/1/33377Bundesministerium für Bildung, Wissenschaft und Forschung Era-Net grant 01KT1801, MIRACUM Consortium grant 01ZZ1801A, Foundation Leducq, ERA Network grant EXPERTDeutsche Forschungsgemeinschaft KFO FOR311-2, TH903/20-1Molecular Medicine program of the Hannover Biomedical Research School (HBRS) PhD fellowship
6 · The paper itself

Abstract

Integrative bioinformatics is an emerging field in the big data era, offering a steadily increasing number of algorithms and analysis tools. However, for researchers in experimental life sciences it is often difficult to follow and properly apply the bioinformatical methods in order to unravel the complexity and systemic effects of omics data. Here, we present an integrative bioinformatics pipeline to decipher crucial biological insights from global transcriptome profiling data to validate innovative therapeutics. It is available as a web application for an interactive and simplified analysis without the need for programming skills or deep bioinformatics background. The approach was applied to an ex vivo cardiac model treated with natural anti-fibrotic compounds and we obtained new mechanistic insights into their anti-fibrotic action and molecular interplay with miRNAs in cardiac fibrosis. Several gene pathways associated with proliferation, extracellular matrix processes and wound healing were altered, and we could identify micro (mi) RNA-21-5p and miRNA-223-3p as key molecular components related to the anti-fibrotic treatment. Importantly, our pipeline is not restricted to a specific cell type or disease and can be broadly applied to better understand the unprecedented level of complexity in big data research.

Indexed as

Computational BiologyFibrosisGene Expression ProfilingGene Regulatory NetworksHumansMicroRNAsRNA, MessengerTranscriptomeWorkflowMicroRNAsRNA, Messengeralgorithmbig datacardiac fibrosisintegrative bioinformaticsmiRNAsnatural compoundstranscriptomicsweb application

Identifiers

PMID32630753
PMCPMC7370212
OpenAlexW3040650511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.